Skip to main content

Eczema News (Page 3)

FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis

TARRYTOWN, N.Y. and PARIS, May 26, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupi...

FDA Approves Dupixent (dupilumab) for Eczema

March 28, 2017 – The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for...

FDA Approves Eucrisa (crisaborole) for Eczema

December 14, 2016 – The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older....

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Dermatitis

Related drug support groups

prednisone, methotrexate, clobetasol, Dupixent, fluocinonide, dexamethasone, desonide, dupilumab, halobetasol